Our main fields are research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients. Grindeks specialises in heart and cardiovascular, CNS and anti-cancer medication.
Our range of products covers a successful combination of original products and generics, including original products Mildronate® and Ftorafur® and more than 100 forms of effective and safe generics. Currently, Grindeks produces 25 active pharmaceutical ingredients (API).
International business development of both APIs in regulated markets (US, EU, Japan, etc.) and finished dosage forms (FDF) in Europe and emerging markets; co-development and out-licensing of existing and new APIs and FDFs; Contract manufacturing of APIs and FDFs (oral, ointment & syrup facilities); chemical and microbiological analytical testing services.